Skip to main content

Vazquez Chris's Form 4 filing

Biodesix Inc (BDSX) · filed Feb 12, 2025

Accession no.
0000905148-25-000528
Filed
Feb 12, 2025
Trade date
Feb 10-11, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.34K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Vazquez ChrisCIK 0001980594Officer (Chief Accounting Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 10, 2025Common StockMOption exerciseAcquired+9,666––21,253Direct
Feb 11, 2025Common StockSSaleDisposed−3,630$0.92−$3,339.617,623Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 10, 2025Common StockMOption exerciseDisposed−601$0.00$02,407Direct
Feb 10, 2025Common StockMOption exerciseDisposed−4,694$0.00$09,388Direct
Feb 10, 2025Common StockMOption exerciseDisposed−4,371$0.00$013,112Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)